2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy And Planning 2018, 33: 528-538. PMID: 29529282, PMCID: PMC5894072, DOI: 10.1093/heapol/czy018.Peer-Reviewed Original Research
2012
Vaccine research and development
Hecht R, Jamison D, Augenstein J, Partridge G, Thorien K. Vaccine research and development. 2012, 299-334. DOI: 10.1017/cbo9781139236805.009.Peer-Reviewed Original ResearchAIDS vaccineInternational AIDS Vaccine InitiativeAnti-retroviral therapyImmune deficiency syndromeAIDS vaccine developmentTime AIDSHIV infectionDeficiency syndromeVaccine researchNew infectionsVaccine InitiativeVaccine developmentTreatment programInfectious diseasesVaccineInfectionPercent efficacyAIDSPreventionEpidemicTreatmentYearsPercentUniversal accessHIV